These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21366301)

  • 1. Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.
    Velmourougane G; Harbut MB; Dalal S; McGowan S; Oellig CA; Meinhardt N; Whisstock JC; Klemba M; Greenbaum DC
    J Med Chem; 2011 Mar; 54(6):1655-66. PubMed ID: 21366301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the Pathway and Dynamics of Bestatin Inhibition of the Plasmodium falciparum M1 Aminopeptidase PfA-M1.
    Yang W; Riley BT; Lei X; Porebski BT; Kass I; Buckle AM; McGowan S
    ChemMedChem; 2018 Dec; 13(23):2504-2513. PubMed ID: 30318749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.
    McGowan S; Porter CJ; Lowther J; Stack CM; Golding SJ; Skinner-Adams TS; Trenholme KR; Teuscher F; Donnelly SM; Grembecka J; Mucha A; Kafarski P; Degori R; Buckle AM; Gardiner DL; Whisstock JC; Dalton JP
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2537-42. PubMed ID: 19196988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Plasmodium falciparum M17 aminopeptidase and significance for the design of drugs targeting the neutral exopeptidases.
    McGowan S; Oellig CA; Birru WA; Caradoc-Davies TT; Stack CM; Lowther J; Skinner-Adams T; Mucha A; Kafarski P; Grembecka J; Trenholme KR; Buckle AM; Gardiner DL; Dalton JP; Whisstock JC
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2449-54. PubMed ID: 20133789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.
    Harbut MB; Velmourougane G; Dalal S; Reiss G; Whisstock JC; Onder O; Brisson D; McGowan S; Klemba M; Greenbaum DC
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E526-34. PubMed ID: 21844374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
    Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
    J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17.
    Drinkwater N; Bamert RS; Sivaraman KK; Paiardini A; McGowan S
    Proteins; 2015 Apr; 83(4):789-95. PubMed ID: 25645579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactions.
    Drinkwater N; Vinh NB; Mistry SN; Bamert RS; Ruggeri C; Holleran JP; Loganathan S; Paiardini A; Charman SA; Powell AK; Avery VM; McGowan S; Scammells PJ
    Eur J Med Chem; 2016 Mar; 110():43-64. PubMed ID: 26807544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A naturally variable residue in the S1 subsite of M1 family aminopeptidases modulates catalytic properties and promotes functional specialization.
    Dalal S; Ragheb DRT; Schubot FD; Klemba M
    J Biol Chem; 2013 Sep; 288(36):26004-26012. PubMed ID: 23897806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LYP3, a new bestatin derivative for aminopeptidase N inhibition.
    Luan Y; Ma C; Sui Z; Wang X; Feng J; Liu N; Jing F; Wang Y; Li M; Fang H; Xu W
    Med Chem; 2011 Jan; 7(1):32-6. PubMed ID: 21235517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based development of potent Plasmodium falciparum M1 and M17 aminopeptidase selective and dual inhibitors via S1'-region optimisation.
    Calic PPS; Vinh NB; Webb CT; Malcolm TR; Ngo A; Lowes K; Drinkwater N; McGowan S; Scammells PJ
    Eur J Med Chem; 2023 Feb; 248():115051. PubMed ID: 36634455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
    Flipo M; Beghyn T; Leroux V; Florent I; Deprez BP; Deprez-Poulain RF
    J Med Chem; 2007 Mar; 50(6):1322-34. PubMed ID: 17326615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Plasmodium falciparum malaria M1 alanyl aminopeptidase (PfA-M1): insights of catalytic mechanism and function from MD simulations.
    Jones PM; Robinson MW; Dalton JP; George AM
    PLoS One; 2011; 6(12):e28589. PubMed ID: 22205955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoproteomics validates selective targeting of
    Giannangelo C; Challis MP; Siddiqui G; Edgar R; Malcolm TR; Webb CT; Drinkwater N; Vinh N; Macraild C; Counihan N; Duffy S; Wittlin S; Devine SM; Avery VM; De Koning-Ward T; Scammells P; McGowan S; Creek DJ
    Elife; 2024 Jul; 13():. PubMed ID: 38976500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
    Salomon E; Schmitt M; Mouray E; McEwen AG; Bounaadja L; Torchy M; Poussin-Courmontagne P; Alavi S; Tarnus C; Cavarelli J; Florent I; Albrecht S
    Bioorg Chem; 2020 May; 98():103750. PubMed ID: 32182520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
    Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
    Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
    Ruggeri C; Drinkwater N; Sivaraman KK; Bamert RS; McGowan S; Paiardini A
    PLoS One; 2015; 10(9):e0138957. PubMed ID: 26406322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.